Key result
COVID-19 mRNA-1273 vaccination is linked to rare multisystem inflammatory syndrome with fulminant myocarditis and appendicitis.
Why the study?
Fulminant myocarditis and acute appendicitis occurring after COVID-19 mRNA vaccination require detailed clinical characterization.
Case Report (n=1)
Multisystem inflammatory syndrome presenting as fulminant myocarditis and acute appendicitis can rarely occur after COVID-19 mRNA vaccination and may be successfully managed with mechanical circulatory support and immunomodulatory therapy.
Alerts to possible delayed fulminant myocarditis after mRNA-1273; single case leaves incidence and causality open.
A 19-year-old Japanese man was hospitalized for cardiogenic shock 28 days after receiving a second dose of the coronavirus disease 2019 (COVID-19) mRNA-1273 vaccine. He had had a high fever for three days with vomiting and abdominal pain before arriving at our hospital. The patient visited a local hospital and was diagnosed with heart failure and acute appendicitis. An endomyocardial biopsy specimen showed myocarditis. Thereafter, Impella CP left ventricular assist device implantation and venoarterial peripheral extracorporeal membranous oxygenation were initiated immediately along with inotropic support and steroid pulse therapy. Given these findings, he was finally diagnosed with multiple inflammatory syndrome and fulminant myocarditis.
No takes yet. Share an insight, caveat, or question.
Kawano et al. (2022) conducted a case report in Fulminant myocarditis and acute appendicitis (MIS-C) (n=1). COVID-19 mRNA-1273 vaccine was evaluated on Development of fulminant myocarditis and acute appendicitis. A 19-year-old man developed multisystem inflammatory syndrome with fulminant myocarditis and acute appendicitis 28 days after receiving the second dose of the COVID-19 mRNA-1273 vaccine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: